Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Rodriguez

Showing results (331-340 of 343) with videos related to

Pageof 35
Sort By:
Science Translational Medicine|August 20, 2025
Synchronized dynamics of dengue across the AmericasTalia M Quandelacy, Maria F Vincente-González, Maria Eugenia Grillet, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Imported malaria predominates in near-elimination settings in Southwestern UgandaMonica Mbabazi, Shahiid Kiyaga, Thomas Katairo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long readsAyse Keskus, Asher Bryant, Tanveer Ahmad, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2019
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the communityOctavio Rodríguez-Gómez, Adrián Rodrigo, Fátima Iradier, et al.
Nature Biotechnology|April 4, 2025
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencingAyse G Keskus, Asher Bryant, Tanveer Ahmad, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Expert Opinion on Biological Therapy|December 14, 2021
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in ItalyAntonio Tursi, Giammarco Mocci, Leonardo Allegretta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19Michael J Peluso, J Daniel Kelly, Scott Lu, et al.
Open Forum Infectious Diseases|February 2, 2022
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for MeasurementMichael J Peluso, J Daniel Kelly, Scott Lu, et al.
Pageof 35

Showing results (331-340 of 343) with videos related to

Sort By:
Pageof 35
Science Translational Medicine|August 20, 2025
Synchronized dynamics of dengue across the AmericasTalia M Quandelacy, Maria F Vincente-González, Maria Eugenia Grillet, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Imported malaria predominates in near-elimination settings in Southwestern UgandaMonica Mbabazi, Shahiid Kiyaga, Thomas Katairo, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long readsAyse Keskus, Asher Bryant, Tanveer Ahmad, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2019
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the communityOctavio Rodríguez-Gómez, Adrián Rodrigo, Fátima Iradier, et al.
Nature Biotechnology|April 4, 2025
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencingAyse G Keskus, Asher Bryant, Tanveer Ahmad, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Expert Opinion on Biological Therapy|December 14, 2021
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in ItalyAntonio Tursi, Giammarco Mocci, Leonardo Allegretta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19Michael J Peluso, J Daniel Kelly, Scott Lu, et al.
Open Forum Infectious Diseases|February 2, 2022
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for MeasurementMichael J Peluso, J Daniel Kelly, Scott Lu, et al.
Pageof 35